Works matching IS 17562856 AND DT 2017 AND VI 10 AND IP 4
Results: 3
Diclofenac potassium for oral solution (CAMBIA<sup>®</sup>) in the acute management of a migraine attack: clinical evidence and practical experience.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 4, p. 217, doi. 10.1177/1756285616684494
- By:
- Publication type:
- Article
Fingolimod initiation in multiple sclerosis patients is associated with potential beneficial cardiovascular autonomic effects.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 4, p. 191, doi. 10.1177/1756285616682936
- By:
- Publication type:
- Article
Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 4, p. 211, doi. 10.1177/1756285616682676
- By:
- Publication type:
- Article